USPTO 2015–2025 USPTO PatentsView US Corporation

Maculogix, Inc.

USPTO PatentsView assignee record - 15 granted patents across 3 technology areas, recorded in grant years 2020–2022. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).

RSS updates for this company

The verdict

According to USPTO PatentsView, Maculogix ranks #18,870 of 49,997 tracked US assignees by granted-patent volume, with 15 patents across 3 technology areas.

#18,870
of 49,997 US assignees by volume
31st percentile
by Innovation Score (29.6/100)
10.5
avg claims per patent

USPTO PatentsView assignee plate

Corpus R18870 · US Corporation #18,870 · 15 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-PAR · TYPE-USCORP · SPAN-YRS · BOOK-RICH

  • GRANTS-MICRO 15 grants
  • MID-PACK #18,870/49,997
  • PHOTO-FINISH Lonza Cologne
  • CPC-NARROW A61B · 3 areas
  • INNOV-THIN 29.6/100
  • CLAIMS-PAR 10.5 claims/avg
  • TYPE-USCORP US Corporation
  • SPAN-YRS 2020–2022 · 3y
  • BOOK-RICH 9/10 fields

Nearest grant-volume peer: Lonza Cologne GmbH (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Maculogix’s 29.6 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Maculogix

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Maculogix's Innovation Score is 29.6/100 (31st percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Maculogix?

Each dot is one of Maculogix’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Maculogix’s own 10.5 claims/patent is at or below the 16.7 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Maculogix vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 14.914.91515.1 051015202530 Granted patents (volume) Avg claims / patent Lonza Cologne GmbH - 15, 14.47Lonza CologneLumencor, Inc. - 15, 20.87LumencorLumotive, Inc. - 15, 24.6LumotiveM87, Inc. - 15, 20.87M87MAP Pharmaceuticals, Inc. - 15, 9.73MAP Pharmaceutica…Mappedin Inc. - 15, 18.8MappedinMarel Iceland EHF - 15, 16.73Marel Iceland EHFMastronardi Produce Ltd. - 15, 5.73Mastronardi Produ…Maculogix, Inc. - 15, 10.47Maculogix
Maculogix vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Maculogix's grants concentrate

Maculogix, Inc. is a focused PatentsView assignee: 3 CPC subclasses with 46.7% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2022 (8 grants) versus a trough of 1 in 2020. By volume, Maculogix sits between Lonza Cologne GmbH and Mastronardi Produce Ltd..

Maculogix's three-year grant acceleration

Maculogix, Inc. shows 8 grants in 2022–2024 against only 7 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at Maculogix's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Maculogix holds 15 patents at rank #18,865, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Maculogix

By rank, the assignees closest to #18,865 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in Maculogix's primary technology class.

Maculogix's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

30 31st percentile higher than 31% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

0246810 202020212022 8
USPTO utility patent grants by year · 2020–2022

Grants by year

Teal-shaded recent years (2020–present) versus the 2020–2019 baseline. Full figures in the table below.

View data table
Maculogix, Inc. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2020 1 6.7%
2021 6 40.0%
2022 8 53.3%

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

Maculogix, Inc.'s patent record in context - here's where to go next.

  • Maculogix, Inc.'s lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 46.7% of its portfolio - see every assignee active in that class. Explore A61B
  • Ranked #18,870 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Maculogix, Inc. against Lonza Cologne GmbH, an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 29.6/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.